51. Activation of gp130 signaling in T cells drives TH17-mediated multi-organ autoimmunity.
- Author
-
Baumgartner, Francis, Bamopoulos, Stefanos A., Faletti, Laura, Hsiao, Hsiang-Jung, Holz, Maximilian, Gonzalez-Menendez, Irene, Boldo, Llorenç, Horne, Arik, Gosavi, Sanket, Özerdem, Ceren, Singh, Nikita, Liebig, Sven, Ramamoorthy, Senthilkumar, Lehmann, Malte, Demel, Uta, Kühl, Anja A., Wartewig, Tim, Ruland, Jürgen, Wunderlich, Frank T., and Schick, Markus
- Subjects
T cells ,REGULATORY T cells ,T cell differentiation ,AUTOIMMUNITY ,GAIN-of-function mutations ,CELL communication - Abstract
The IL-6–gp130–STAT3 signaling axis is a major regulator of inflammation. Activating mutations in the gene encoding gp130 and germline gain-of-function mutations in STAT3 (STAT3
GOF ) are associated with multi-organ autoimmunity, severe morbidity, and adverse prognosis. To dissect crucial cellular subsets and disease biology involved in activated gp130 signaling, the gp130-JAK-STAT3 axis was constitutively activated using a transgene, L-gp130, specifically targeted to T cells. Activating gp130 signaling in T cells in vivo resulted in fatal, early onset, multi-organ autoimmunity in mice that resembled human STAT3GOF disease. Female mice had more rapid disease progression than male mice. On a cellular level, gp130 signaling induced the activation and effector cell differentiation of T cells, promoted the expansion of T helper type 17 (TH 17) cells, and impaired the activity of regulatory T cells. Transcriptomic profiling of CD4+ and CD8+ T cells from these mice revealed commonly dysregulated genes and a gene signature that, when applied to human transcriptomic data, improved the segregation of patients with transcriptionally diverse STAT3GOF mutations from healthy controls. The findings demonstrate that increased gp130-STAT3 signaling leads to TH 17-driven autoimmunity that phenotypically resembles human STAT3GOF disease. Editor's summary: Gain-of-function mutations in the transcription activator STAT3 cause an autoimmune disease called STAT3GOF syndrome. A challenging feature of this syndrome is the phenotypic heterogeneity of the individual STAT3 mutations. By manipulating an upstream activator instead of STAT3 itself, Baumgartner et al. developed a mouse model that recapitulated more aspects of the disease. Mice with constitutive activation of the cytokine receptor subunit gp130 in T cells developed fatal, multi-organ inflammation with changes in T cell profiles and gene expression that were similar to those in patients with STAT3GOF autoimmunity, suggesting that this model may be useful for investigating the disease and exploring therapeutic options. —Leslie K. Ferrarelli [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF